These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4085735)

  • 1. [Severe cardiomyopathy in a woman with intermediate beta-thalassemia. Regression of cardiac failure with desferrioxamine].
    Mancuso L; Iacona MA; Marchi S; Rigano P; Geraci E
    G Ital Cardiol; 1985 Sep; 15(9):916-20. PubMed ID: 4085735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The echocardiography in thalassemia major (author's transl)].
    Musumeci S; Schiliro G; Romeo MA; Di Gregorio F; Russo G; Scibilia G
    Pediatr Med Chir; 1981; 3(2-3):219-22. PubMed ID: 6211659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adiastole caused by a secondary cardiac hemochromatosis. Successful treatment with an iron chelating agent].
    Baudouy P; Lombrail P; Azancot I; Piekarski A; Martin E; Slama R
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1240-6. PubMed ID: 6418103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure in beta-thalassemia syndromes: a decade of progress.
    Hahalis G; Alexopoulos D; Kremastinos DT; Zoumbos NC
    Am J Med; 2005 Sep; 118(9):957-67. PubMed ID: 16164878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac status in well-treated patients with thalassemia major.
    Aessopos A; Farmakis D; Hatziliami A; Fragodimitri C; Karabatsos F; Joussef J; Mitilineou E; Diamanti-Kandaraki E; Meletis J; Karagiorga M
    Eur J Haematol; 2004 Nov; 73(5):359-66. PubMed ID: 15458515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac abnormalities in the thalassaemia syndromes.
    Yee H; Mra R; Nyunt KM
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):414-21. PubMed ID: 6523177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major.
    Wacker P; Halperin DS; Balmer-Ruedin D; Oberhansli I; Wyss M
    Chest; 1993 Apr; 103(4):1276-8. PubMed ID: 8131484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare cause of reversible dilated cardiomyopathy: hypocalcemia.
    Avsar A; Dogan A; Tavli T
    Echocardiography; 2004 Oct; 21(7):609-12. PubMed ID: 15488088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of and obstacles to iron cardiomyopathy in thalassemia.
    Peng CT; Chang JS; Wu KH; Tsai CH; Lin HS
    Front Biosci; 2008 May; 13():5975-87. PubMed ID: 18508636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cardiac manifestations of thalassemia major: natural history, noninvasive cardiac diagnostic studies and results of cardiac catheterization.
    Ehlers KH; Levin AR; Klein AA; Markenson AL; O'Loughlin JE; Engle MA
    Cardiovasc Clin; 1981; 11(2):171-86. PubMed ID: 7214380
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictors of death from congestive heart failure in hypertrophic cardiomyopathy.
    Ikeda H; Maki S; Yoshida N; Murohara T; Adachi H; Koga Y; Imaizumi T
    Am J Cardiol; 1999 Apr; 83(8):1280-3, A9. PubMed ID: 10215301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thalassemia cardiomyopathy].
    Fourcade L; Paule P; Mioulet D; Braem L; Jaubert MP; Quilici J
    Med Trop (Mars); 2007 Dec; 67(6):617-9. PubMed ID: 18300526
    [No Abstract]   [Full Text] [Related]  

  • 13. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
    Giardina PJ; Grady RW
    Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.
    Borgna-Pignatti C; Rugolotto S; De Stefano P; Zhao H; Cappellini MD; Del Vecchio GC; Romeo MA; Forni GL; Gamberini MR; Ghilardi R; Piga A; Cnaan A
    Haematologica; 2004 Oct; 89(10):1187-93. PubMed ID: 15477202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congestive heart failure and treatment in thalassemia major.
    Aessopos A; Kati M; Tsironi M
    Hemoglobin; 2008; 32(1-2):63-73. PubMed ID: 18274984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous desferrioxamine: the effect of three years' treatment on liver, iron, serum ferritin, and comments on echocardiography.
    Flynn DM; Hoffbrand AV; Politis D
    Birth Defects Orig Artic Ser; 1982; 18(7):347-53. PubMed ID: 6819017
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies of left-ventricular function in anemia due to beta-thalassemia.
    Lewis BS; Lewis N; Dagan I; Rachmilewitz EA; Gotsman MS; Sapoznikov D
    Isr J Med Sci; 1982 Sep; 18(9):928-34. PubMed ID: 7141853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac resynchronization therapy in non-ischemic cardiomyopathy].
    Weretka S; Rüb N; Weig HJ; Laszlo R; Dörnberger V; Gawaz M; Schreieck J
    Dtsch Med Wochenschr; 2008; 133 Suppl():F2. PubMed ID: 18850520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Iron overload in a beta thalassemia heterozygote of the intermediate type in a subject of Alsation origin. Results of iron chelation treatment].
    North ML; Lang JM; Bergerat JP; Giron C; Oberling F; Mayer S
    Nouv Rev Fr Hematol (1978); 1984; 26(5):317-21. PubMed ID: 6334273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thalassemic cardiopathy: serial echocardiographic evaluation].
    Bosi S; Spinolo L; Cavallini B; Guadagni C; Lama A; Santarelli R; Baccini C
    G Clin Med; 1982 Apr; 63(4):248-54. PubMed ID: 7128980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.